Related Experiment Video
Updated: Oct 9, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients
J Gené1, A Azón-Masoliver, J Guarro
1Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Hospital Universitari de Sant Joan, 43201-Reus, Tarragona, Spain. jgd@fmcs.urv.es
Abstract:
We report a case of primary cutaneous infection by the emerging fungus Aspergillus ustus in an immunosuppressed patient after a domestic accident. The patient failed to respond to itraconazole and died before receiving a new treatment with amphotericin B. There have been eight other cases reported since 1973, and only two patients survived the infection. In vitro susceptibility testing of seven antifungal drugs showed that terbinafine and the new azole derivative UR-9825 were the most active against this fungus.
Insights
Primary cutaneous Aspergillus ustus infection is a rare and often fatal fungal disease in immunosuppressed individuals. Terbinafine and UR-9825 showed promising in vitro activity against this emerging pathogen.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Case Study
Background:
- Primary cutaneous fungal infections can be severe, particularly in immunocompromised patients.
- Aspergillus ustus is an emerging fungal pathogen with limited reported cases.
- Domestic accidents can lead to opportunistic infections in vulnerable individuals.
Observation:
- A case of primary cutaneous Aspergillus ustus infection occurred in an immunosuppressed patient following a domestic accident.
- The patient did not respond to standard antifungal treatment with itraconazole.
- The infection proved fatal before alternative treatment could be administered.
Findings:
- There are only eight previously reported cases of Aspergillus ustus cutaneous infection since 1973.
- Survival rates for this infection are extremely low, with only two documented survivors.
- In vitro testing revealed terbinafine and a novel azole derivative, UR-9825, as the most potent antifungal agents against Aspergillus ustus.
Implications:
- This case highlights the aggressive nature and poor prognosis of primary cutaneous Aspergillus ustus infections.
- Newer antifungal agents like terbinafine and UR-9825 warrant further investigation for treating this rare but dangerous infection.
- Enhanced vigilance and prompt, appropriate antifungal therapy are crucial for managing immunosuppressed patients with suspected Aspergillus infections.
Related Concept Videos
Staphylococcal Skin Infections
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Ascomycota
Cryptococcal Meningitis
Candidiasis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
